Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,526 signal articles · 28 in last 24h · 122,310 total before filter · latest 1h ago
28last 24h
1249last 7d
210● bullish (7d)
150● bearish (7d)
205publishers
AllMacro211Earnings429M&A97Regulatory24Product9Analyst10
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Teladoc (NYSE:TDOC) Surprises With Q1 CY2026 Sales But Stock Drops
StockStory115d agobearish
Teladoc (NYSE:TDOC) Surprises With Q1 CY2026 Sales But Stock Drops

Digital medical services platform Teladoc Health (NYSE:TDOC) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.5% year on year to $613.8 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $611.5 million was less impressive, coming in 2% below expectations. Its GAAP loss of $0.36 per share was 4.7% below analysts’ consensus estimates.

Treasury Sell-off Isn’t All That Alarming–Yet
Barrons.com115d agobearish
Treasury Sell-off Isn’t All That Alarming–Yet

Bond yields nearly rose to levels seen in March during the height of fears over the Iran War–but it shouldn’t frighten investors. Much of the gains in yields came ahead of that hour as the Treasury market sold off alongside rising oil prices. Multiple Fed presidents didn’t support the inclusion of an easing bias, or potential lower rates in the future, in the FOMC statement, telling traders the Fed is likely closer to hikes than cuts.

Treasuries Extend Selloff After Fed Decision
Barrons.com115d agobearish
Treasuries Extend Selloff After Fed Decision

The U.S. debt market selloff picked up after the Fed left rates steady again. The Fed left rates steady but there was a higher level of dissent among participants. Fed governor Stephen Miran has typically dissented, but this time there were also multiple Fed presidents who didn’t support statement language including “an easing bias.”

62-year-old sports retail giant cuts 100s of jobs
TheStreet115d agobearish
62-year-old sports retail giant cuts 100s of jobs

Sportswear is still a growth market, but not every brand is winning equally. North American retail sales of sports-related apparel and footwear were projected to reach $173 billion in 2025 and rise to $209 billion by 2029, according to a McKinsey & Company report. But the report also ...

Wall Street Slashes Spotify Price Targets After Q1 Miss: Is the Subscriber Story Cracking?
24/7 Wall St.115d agobearish
Wall Street Slashes Spotify Price Targets After Q1 Miss: Is the Subscriber Story Cracking?

Spotify (NYSE:SPOT) faces sharply divided Wall Street sentiment after its Q1 2026 earnings, with four firms cutting price targets while Rosenblatt issued a contrarian upgrade. Spotify stock closed at $434.20 on April 28, capping a 17% one-week decline. The reaction is striking given headline numbers beat expectations. Spotify’s EPS of $3.45 topped the $2.95 consensus, ... Wall Street Slashes Spotify Price Targets After Q1 Miss: Is the Subscriber Story Cracking?

NVR, Inc. (NVR)’s First-quarter Profit Drops
Insider Monkey115d agobearish
NVR, Inc. (NVR)’s First-quarter Profit Drops

NVR, Inc. (NYSE:NVR) is one of the 10 Best Housing Stocks to Buy in 2026. On April 22, 2026, Reuters reported that NVR, Inc. (NYSE:NVR) reduced profit and revenue in the first quarter of 2026 because of the rising costs and economic uncertainties that weighed on demand. Shares tumbled 6% in morning trading. The corporation […]

Robinhood Tumbles 11%, Webull Drops 5%, Coinbase Slides 8% – Here’s Why
24/7 Wall St.115d agobearish
Robinhood Tumbles 11%, Webull Drops 5%, Coinbase Slides 8% – Here’s Why

Shares of Robinhood (NASDAQ:HOOD) are down about 12% in early trading Wednesday after the brokerage delivered a disappointing Q1 2026 earnings report. The stock is changing hands near $72 after closing Tuesday at $82.07. The selloff stands out as Robinhood’s peers are following to the downside. Webull (NASDAQ:BULL) stock is down 5% to $6.77, and ... Robinhood Tumbles 11%, Webull Drops 5%, Coinbase Slides 8% – Here’s Why

Warren Buffett Will Never Sell These 4 Favorite ‘Forever’ Dividend Giants
24/7 Wall St.115d agobearish
Warren Buffett Will Never Sell These 4 Favorite ‘Forever’ Dividend Giants

Warren Buffett stepped down as CEO of Berkshire Hathaway on December 31, 2025, after six decades leading the conglomerate he transformed from a struggling textile mill into a $1 trillion empire. The “Oracle of Omaha” left his successor, Greg Abel, with a very concentrated portfolio: almost 65% of Berkshire’s $381 billion portfolio is invested in ... Warren Buffett Will Never Sell These 4 Favorite ‘Forever’ Dividend Giants

Voyager Technologies Links Yonsei Pact And NASA Mission To Valuation Gap
Simply Wall St.115d agobearish
Voyager Technologies Links Yonsei Pact And NASA Mission To Valuation Gap

Voyager Technologies (NYSE:VOYG) has formed an alliance with Yonsei University to advance the VISTA science park ecosystem. The collaboration is intended to support global research ties and commercial space technology development. Voyager has also secured a NASA contract for the VOYG-1 private astronaut mission to the International Space Station. The new VOYG-1 mission extends Voyager's role in privately operated human spaceflight in low Earth orbit. For investors tracking space...

Rambus (RMBS) Loses 21% on Downgrade to Neutral
Insider Monkey116d agobearish
Rambus (RMBS) Loses 21% on Downgrade to Neutral

Rambus Inc. (NASDAQ:RMBS) is one of the 10 Stocks Reeling From Huge Losses. Rambus dropped for a second day on Tuesday, slashing 21.17 percent to close at $111.27 apiece, as investors took path from an investment firm’s rating downgrade amid the ongoing shortage of memory products. In a market note, Baird downgraded its rating for […]

Erasca Stock Sinks 48% in Race for Pancreatic Cancer Miracle Drug. What’s Behind the Sell-Off.
Barrons.com116d agobearish
Erasca Stock Sinks 48% in Race for Pancreatic Cancer Miracle Drug. What’s Behind the Sell-Off.

A confluence of safety concerns and underwhelming clinical data sent Erasca stock into a historic tailspin on Tuesday. Erasca late Monday reported positive Phase 1 trial results for ERAS-0015, a therapeutic drug candidate tailored to patients with lung and pancreatic cancer. Investors quickly drew parallels to daraxonrasib, the high-profile lead asset from Revolution Medicines Daraxonrasib has been on the receiving end of a storm of media coverage following an endorsement from former Nebraska Sen. Ben Sasse.

Why Rambus Plunged Today
Motley Fool116d agobearish
Why Rambus Plunged Today

Despite strong demand for AI-related memory products, the DRAM interface product and IP company plunged after a strong run.